This list is an analysis based on recent market events. It's not an investment recommendation.
Cytogen, Inc., a biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea. The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips; IF stainers, automated immunofluorescent staining system; and cell image analyzers, which help captures immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies. The company sells its products under the Smart Biopsy brand name. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea.
FAQs
What is Cytogen stock price today?▼
The current price of 217330.KQ is ₩2,225 KRW — it has decreased by -4.09% in the past 24 hours. Watch Cytogen stock price performance more closely on the chart.
What is Cytogen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Cytogen stocks are traded under the ticker 217330.KQ.
Is Cytogen stock price growing?▼
217330.KQ stock has fallen by -9.18% compared to the previous week, the month change is a -30.69% fall, over the last year Cytogen has showed a -20.68% decrease.
What is Cytogen market cap?▼
Today Cytogen has the market capitalization of 51.33B
What is Cytogen revenue for the last year?▼
Cytogen revenue for the last year amounts to 3.18B KRW.
What is Cytogen net income for the last year?▼
217330.KQ net income for the last year is -15.77B KRW.
How many employees does Cytogen have?▼
As of November 3, 2026, the company has 42 employees.
In which sector is Cytogen located?▼
Cytogen operates in the Energy sector.
When did Cytogen complete a stock split?▼
The last stock split for Cytogen was on September 28, 2022 with a ratio of 2:1.
Where is Cytogen headquartered?▼
Cytogen is headquartered in Seoul, South Korea.